MLV & Co. Trims PT on Galena Biopharma (GALE) to $5; Believes Investor Reaction is 'Overdone'
Tweet Send to a Friend
MLV & Co. is lowering its price target on Galena Biopharma (Nasdaq: GALE) from $6 to $5, while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
